16 February 2015 : Original article
Challenges in Renal Transplantation in Yemen
Ibrahiem H. El-NonoABDEFG, Khaled A. TelhaCDE, Gamil M. Al-AlimyB, Abdulilah M. GhilanB, Nagieb W. Abu AsbaB, Abdo M. Al-ZkriB, Abdulilah M. Al-AdimiB, Tawfiq H. Al-Ba’adaniDDOI: 10.12659/AOT.891362
Ann Transplant 2015; 20:92-96
Abstract
BACKGROUND: Renal replacement therapy was first introduced in Yemen in 1978 in the form of hemodialysis. Twenty years later, the first renal transplantation was performed. Kidney transplantations were started in socially and financially challenging circumstances in Yemen in 1998. A structured program was established and has been functioning regularly since 2005. A pediatric transplantation program was started in 2011.
MATERIAL AND METHODS: This was a prospective study of 181 transplants performed at the Urology and Nephrology Center between May 1998 and 2012. All transplants were from living related donors. The immunosuppressive protocol consisted initially of double therapy with steroid and mycophenolate mofetil (MMF). Subsequently, triple therapy with addition of a calcineurin inhibitor was introduced. Primary graft function was achieved in 176 (97.2%) recipients.
RESULTS: Cold ischemia time was 48–68 min. Episodes of acute rejection in 12 patients were treated with high-dose steroids. Anti-thymocyte globulin (ATG) was used in cases of vascular or steroid-resistant rejection in 2 patients. The post-transplant complications, either surgical or medical, were comparable to those recorded in the literature.
CONCLUSIONS: Renal transplantation is a good achievement in our country. The patients and graft survival rates are comparable to other reports.
Keywords: Kidney Transplantation, Living Donors, Yemen
In Press
Original article
CD146⁺ Endothelial Cells Facilitate Renal Interstitial Fibrosis Through Endothelial-to-Mesenchymal TransitionAnn Transplant In Press; DOI: 10.12659/AOT.945917
Original article
Effect of Medical Accessibility on Long-Term Survival in Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.944839
Most Viewed Current Articles
05 Apr 2022 : Original article 13,217
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,665
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,806
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,520
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860